CSS
NGNE icon

Cubist Systematic Strategies’s Neurogene NGNE Stock Holding History

Cubist Systematic Strategies’s Portfolio NGNE Stock Details NGNE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		$39.2K Buy
+2,262
New +$45.4K ﹤0.01% 2870
2024
Q2 		– Sell
-10,720
Closed -$546K – 3684
2024
Q1 		$546K Buy
+10,720
New +$358K ﹤0.01% 2561
2023
Q2 		– Sell
-672
Closed -$9.41K – 4035
2023
Q1 		$9.41K Buy
+672
New +$7.88K ﹤0.01% 3727
2022
Q4 		– Sell
-306
Closed -$3.16K – 4182
2022
Q3 		$4K Sell
306
-163
-35% -$3.33K ﹤0.01% 4328
2022
Q2 		$10K Sell
469
-1,246
-73% -$30.4K ﹤0.01% 4270
2022
Q1 		$64K Buy
1,715
+751
+78% +$43.8K ﹤0.01% 3333
2021
Q4 		$93K Buy
964
+769
+394% +$93.7K ﹤0.01% 3214
2021
Q3 		$28K Sell
195
-80
-29% -$12.2K ﹤0.01% 2874
2021
Q2 		$51K Buy
275
+220
+400% +$48.7K ﹤0.01% 2790
2021
Q1 		$14K Buy
55
+26
+90% +$6.64K ﹤0.01% 2777
2020
Q4 		$8K Buy
+29
New +$7.09K ﹤0.01% 2520
2020
Q3 		– Sell
-667
Closed -$162K – 2580
2020
Q2 		$221K Buy
667
+181
+37% +$47.2K ﹤0.01% 1990
2020
Q1 		$111K Sell
486
-601
-55% -$124K ﹤0.01% 1889
2019
Q4 		$268K Buy
+1,087
New +$108K ﹤0.01% 1909
2018
Q2 		– Sell
-304
Closed -$86K – 1955
2018
Q1 		$86K Sell
304
-133
-30% -$36.7K 0.01% 1615
2017
Q4 		$103K Buy
+437
New +$102K 0.01% 1678

Other funds holding NGNE

SB
Samsara BioCapital Palo Alto, California $1.03B AUM 214.94% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
Toronto Dominion Bank
Toronto Dominion Bank Toronto, Ontario, Ontario, Canada $69.7B AUM 40.86% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Cubist Systematic Strategies's NGNE Position: Q3 2025 in Review

Cubist Systematic Strategies opened a new position in Neurogene (NGNE) in Q3 2025: 2,262 shares worth $39.2K. The stake represents ﹤0.01% of the portfolio and ranks #2870 among its holdings. This is a return to the name: Cubist Systematic Strategies previously reported a position in NGNE as recently as Q1 2024.

Cubist Systematic Strategies first reported a position in NGNE in Q4 2017 and has held it in 16 quarters since. The position peaked at $546K in Q1 2024. 88 funds tracked by Wall St. Rank hold NGNE as of Q3 2025.

  • Cubist Systematic Strategies held 2,262 shares of Neurogene worth $39.2K as of Q3 2025.
  • Neurogene was a new Cubist Systematic Strategies position in Q3 2025.
  • Neurogene made up ﹤0.01% of Cubist Systematic Strategies's portfolio in Q3 2025, its #2870 holding.
  • Cubist Systematic Strategies first reported a position in Neurogene in Q4 2017 and has held it in 16 quarters since.
  • Cubist Systematic Strategies's Neurogene position peaked at $546K in Q1 2024.
  • 88 funds tracked by Wall St. Rank held Neurogene as of Q3 2025.

Based on Cubist Systematic Strategies's 13F filing for Q3 2025, filed 14 Nov 2025.